from Reuters: Health News https://ift.tt/2MNrghS
Friday, July 6, 2018
Friday, July 06, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
LONDON (Reuters) - AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

from Reuters: Health News https://ift.tt/2MNrghS
from Reuters: Health News https://ift.tt/2MNrghS
Related Posts:
LATEST HEALTH NEWSChina's Ministry of Agriculture reported on Tuesday an outbreak of foot and mouth disease in its central province of Henan from Reuters: Health News https://ift.tt/2B9yagr … Read More
LATEST HEALTH NEWS(Reuters Health) - Adults who sleep too little or too much may have an increased risk of heart attack or stroke, say researchers who argue that the best way to think of the harmful effect is in terms of "excess heart age." … Read More
LATEST HEALTH NEWSBiogen's muscle disease treatment Spinraza has been deemed too expensive for use on Britain's state-run health service, even after a price discount offered by the U.S. drugmaker. from Reuters: Health News https://ift.tt/… Read More
LATEST HEALTH NEWS(Reuters Health) - Tests for BRCA1 and BRCA2 - gene mutations that raise the risk of breast and ovarian cancers - are not always done in U.S. women who are eligible to get them, a new study suggests. from Reuters: Health… Read More
LATEST HEALTH NEWS(Reuters Health) - The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while disabling key cellular defenders against infection, a new study suggests. from Reuters: Health News ht… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment